Mark J. Foley - President & CEO, Director at Revance Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
RVNC on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark J. Foley since 4/22/2024

Holdings reported by Mark J. Foley for Revance Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $3.65 Feb 6, 2025 Direct
Common Stock 0 $0 $3.65 Feb 4, 2025 Indirect

Transactions reported by Mark J. Foley for Revance Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.